The Midwest Regional Pulmonary Hypertension Summit occurred on October 14, 2023, in Chicago, IL. The event highlighted the management of PH with other coexisting comorbidities. Leading experts discussed the appropriate risk stratification, management of PH, updates on ERS/ERC guidelines, and optimal patient care practice.
This activity has been designed to meet the educational needs of the interprofessional team, including cardiologists, pulmonologists, echocardiographers, sonographers, nurse practitioners and other clinicians involved in the management of patients with pulmonary hypertension.
After participating in this educational activity, participants should be better able to:
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 4.75 Interprofessional Continuing Education (IPCE) credits for learning and change.
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
Vallerie V. McLaughlin, MD, chair for this educational event, receives research funds from Aerovate, Altavant, Gossamer-Bio, Janssen, Merck and Sonovie; and receives consulting fees from Aerami, Aerovate, Altavant, Bayer, Caremark, L.L.C., Corvista, Gossamer Bio, Janssen, Merck and United Therapeutics.
Michael J. Cuttica, MD, MS, chair for this educational event, receives research funds from United Therapeutics, Bayer and Janssen; and receives consulting fees from United Therapeutics, Bayer and Janssen.
Ruben Mylvaganam, MD, faculty for this educational event, receives research funds from United Therapeutics, Janssen, Bayer Health Care Pharmaceuticals, Insmed and Gossamer Bio; and receives consulting fees from United Therapeutics and Roivant Sciences.
George Hanna, MD, faculty for this educational event, has no relevant financial relationships with ineligible companies.
Dan Schimmel, MD, MS, FACC, FSCAI, faculty for this educational event, receives research funds from Inari medical, Penumbra, Boston Scientific, Medtronic, Abbott Labs and Edwards; and receives consulting fees from Inari medical, Penumbra and Boston Scientific.
Jonathan Haft, MD, faculty for this educational event, has no relevant financial relationships with ineligible companies.
Victor M. Moles, MD, faculty for this educational event, receives research funds from Acceleron Pharma (Merck), and Janssen; and receives consulting fees from United Therapeutics.
Sydney Schacht, DO, faculty for this educational event, has no relevant financial relationships with ineligible companies.
Yasmin Raza, MD, faculty for this educational event, has no relevant financial relationships with ineligible companies.
Ravi B. Patel, MD, MSc, faculty for this educational event, has no relevant financial relationships with ineligible companies.
Thomas Cascino, MD, MSc, FACC, FHFSA, faculty for this educational event, receives research funds from Johnson and Johnson and NHLBI; and receives consulting fees from Merck.
The following planners/reviewers/managers have disclosed:
Prerna Poojary, PhD, planner for this educational event, has no relevant financial relationships with ineligible companies.
William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.
Total CME, LLC., planners and managers have no relevant commercial relationships to disclose.
All the relevant financial relationships for these individuals have been mitigated.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use their clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go, you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Jointly provided by Global Learning Collaborative (GLC) and Total CME, LLC.
This activity is supported by independent educational grants from Actelion Pharmaceuticals US, Division of Janssen Pharmaceuticals and United Therapeutics Corporation.
During the period 11/30/2023 through 11/30/2024, registered participants wishing to receive continuing education credit for this activity must follow these steps:
1. Read the learning objectives and faculty disclosures.
2. Answer a pre-program question.
3. View the program.
4. Complete the post-test with a score of 100%.
5. Complete activity evaluation.
6. Apply for credit and either bank your credits or print your certificate.
For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.
Release Date:
Expiration Date:
